Hayfin Capital Management
Hayfin was founded in 2009 with the ambition of creating one of Europe’s leading investment platforms. They focus on delivering best-in-class risk-adjusted returns for their investors across four strategies: Direct Lending, Special Opportunities, High-Yield Credit and Securitized Credit. Hayfin is a London based firm with offices in Amsterdam, Frankfurt, Mardid, Paris and Luxembourg. They consider their selves value investors, generating differentiated return through hard work, insightful analysis and disciplined investing. Hayfin seeks to recruit and retain exceptionally talented professionals. They believe in being local in each of their markets, and that their diverse mix of nationalities, cultures and languages makes them more connected to these markets. Most of their team are industry generalists, with their edge lying in their origination networks and proven expertise in managing complex restructurings, workouts and liquidations. That said, they employ dedicated, specialist teams in the areas of healthcare (life sciences), shipping (maritime) and real estate, where they believe their focused expertise provides an advantage. They operate across all major European geographies with offices in London, Paris, Madrid, Frankfurt, Luxembourg and Tel Aviv, and have a growing presence in the United States with an office in New York.
KEO World is an innovative FinTech helping Buyers and Suppliers accelerate business growth through all-digital inventory financing and B2B payment solutions. Headquartered in Miami, Florida, KEO operates in the U.S., Mexico and across LATAM by way of its Global Trade program.
ADMA is a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics targeted to niche patient populations for the treatment and prevention of certain infectious diseases. The Company’s target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. ADMA also operates ADMA BioCenters, FDA-licensed source plasma collection facilities which provide a portion of blood plasma for the manufacturing of the Company’s lead product candidate RI-002.
KEO World is an innovative FinTech helping Buyers and Suppliers accelerate business growth through all-digital inventory financing and B2B payment solutions. Headquartered in Miami, Florida, KEO operates in the U.S., Mexico and across LATAM by way of its Global Trade program.
Avadim Technologies is a life sciences company that offers a portfolio of solutions and a strong pipeline across health and wellness areas. Their products improve immune health, neuromuscular health, and skin barrier health.
Amicus Therapeutics, Inc., a biotechnology company, engages in the discovery, development, and commercialization of therapies to treat a range of rare and orphan diseases. The company offers Galafold, an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease. It is also conducting Phase 3 (ATB200-03) clinical study of AT-GAA for Pompe disease. The company has collaboration and license agreements with Nationwide Children's Hospital and University of Pennsylvania. Amicus Therapeutics, Inc. was founded in 2002 and is headquartered in Cranbury, New Jersey.
MiMedx Group developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. They processes the human placental tissue utilizing its proprietary purion process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization.
GC Aesthetics provides high-quality products that help patients feel confident and secure during their breast enhancement journey. It seeks to empower and support individuals on their journey of body transformation. As an international aesthetics market leader with over 30 years of industry experience, it places a premium on innovation and continuous improvement when developing its product portfolio.
Avadim Technologies is a life sciences company that offers a portfolio of solutions and a strong pipeline across health and wellness areas. Their products improve immune health, neuromuscular health, and skin barrier health.
is an employee owned investment manager. It provides its services to Funds and collateralised loan obligations. The firm invests in the fixed income markets. It invests in corporate debt securities, high yield bonds, distressed assets, leveraged loans, and other types of investments. The firm employs fundamental and technical analysis to create its portfolios.
NKD Group is a retail business that specializes in offering a wide range of textiles and home accessories. The company provides fashionable clothing options for men, women, and children, catering to diverse tastes and preferences. Customers can find a variety of items, including dresses, blouses, trousers, and jackets at competitive prices. Additionally, NKD features functional sportswear and home textiles, as well as seasonal decorations. The product assortment is available through both online and offline stores, ensuring accessibility and convenience for shoppers. By regularly updating its offerings with seasonal novelties and trends, NKD aims to meet the evolving needs of residential households and the sports sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.